Icon

CATAPRES-TTS-2 (nda018891)- (0.2MG/24HR)

CLONIDINE LAVIPHARM
0.2MG/24HR
Yes No
2003-May-04 Expired
None None
None No
Catapres-TTS transdermal therapeutic system is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
4 0 3
Total Other Developers None
Drugs with Suitability No
0.2MG/24HR ** ** - 3 -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** ****** ***********, ***. *********** **** **** ****** **, ***** ******, ******** (**) *****, ****** ****** (***) ***
****** ******* **** ** *** ******* ************ **, ***. *********** *** ******* ***, **** **** ****, **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.